SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Lim Michele C.) srt2:(2020-2024)"

Sökning: WFRF:(Lim Michele C.) > (2020-2024)

  • Resultat 11-13 av 13
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  • Ahmad, Abrar, et al. (författare)
  • Precision prognostics for cardiovascular disease in Type 2 diabetes : a systematic review and meta-analysis
  • 2024
  • Ingår i: Communications medicine. - 2730-664X. ; 4
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Precision medicine has the potential to improve cardiovascular disease (CVD) risk prediction in individuals with Type 2 diabetes (T2D).METHODS: We conducted a systematic review and meta-analysis of longitudinal studies to identify potentially novel prognostic factors that may improve CVD risk prediction in T2D. Out of 9380 studies identified, 416 studies met inclusion criteria. Outcomes were reported for 321 biomarker studies, 48 genetic marker studies, and 47 risk score/model studies.RESULTS: Out of all evaluated biomarkers, only 13 showed improvement in prediction performance. Results of pooled meta-analyses, non-pooled analyses, and assessments of improvement in prediction performance and risk of bias, yielded the highest predictive utility for N-terminal pro b-type natriuretic peptide (NT-proBNP) (high-evidence), troponin-T (TnT) (moderate-evidence), triglyceride-glucose (TyG) index (moderate-evidence), Genetic Risk Score for Coronary Heart Disease (GRS-CHD) (moderate-evidence); moderate predictive utility for coronary computed tomography angiography (low-evidence), single-photon emission computed tomography (low-evidence), pulse wave velocity (moderate-evidence); and low predictive utility for C-reactive protein (moderate-evidence), coronary artery calcium score (low-evidence), galectin-3 (low-evidence), troponin-I (low-evidence), carotid plaque (low-evidence), and growth differentiation factor-15 (low-evidence). Risk scores showed modest discrimination, with lower performance in populations different from the original development cohort.CONCLUSIONS: Despite high interest in this topic, very few studies conducted rigorous analyses to demonstrate incremental predictive utility beyond established CVD risk factors for T2D. The most promising markers identified were NT-proBNP, TnT, TyG and GRS-CHD, with the highest strength of evidence for NT-proBNP. Further research is needed to determine their clinical utility in risk stratification and management of CVD in T2D.
  •  
12.
  •  
13.
  • Slieker, Roderick C, et al. (författare)
  • Identification of biomarkers for glycaemic deterioration in type 2 diabetes
  • 2023
  • Ingår i: Nature Communications. - 2041-1723. ; 14, s. 1-18
  • Tidskriftsartikel (refereegranskat)abstract
    • We identify biomarkers for disease progression in three type 2 diabetes cohorts encompassing 2,973 individuals across three molecular classes, metabolites, lipids and proteins. Homocitrulline, isoleucine and 2-aminoadipic acid, eight triacylglycerol species, and lowered sphingomyelin 42:2;2 levels are predictive of faster progression towards insulin requirement. Of ~1,300 proteins examined in two cohorts, levels of GDF15/MIC-1, IL-18Ra, CRELD1, NogoR, FAS, and ENPP7 are associated with faster progression, whilst SMAC/DIABLO, SPOCK1 and HEMK2 predict lower progression rates. In an external replication, proteins and lipids are associated with diabetes incidence and prevalence. NogoR/RTN4R injection improved glucose tolerance in high fat-fed male mice but impaired it in male db/db mice. High NogoR levels led to islet cell apoptosis, and IL-18R antagonised inflammatory IL-18 signalling towards nuclear factor kappa-B in vitro. This comprehensive, multi-disciplinary approach thus identifies biomarkers with potential prognostic utility, provides evidence for possible disease mechanisms, and identifies potential therapeutic avenues to slow diabetes progression.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-13 av 13
Typ av publikation
tidskriftsartikel (11)
annan publikation (1)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (12)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Fitipaldi, Hugo (4)
Motala, Ayesha A (4)
Ma, Ronald C W (4)
Gomez, Maria F (3)
Ahmad, Abrar (3)
Lim, Lee-Ling (3)
visa fler...
Morieri, Mario Luca (3)
Tam, Claudia Ha-Ting (3)
Cheng, Feifei (3)
Chikowore, Tinashe (3)
Dudenhöffer-Pfeifer, ... (3)
Huang, Chuiguo (3)
Kanbour, Sarah (3)
Sarkar, Sudipa (3)
Tye, Sok Cin (3)
Yu, Gechang (3)
Zhang, Yingchai (3)
Provenzano, Michele (3)
Sherifali, Diana (3)
Mathioudakis, Nestor ... (3)
Rossi, M. (2)
Gagliardi, M. (2)
Riess, O (2)
Marder, K (2)
Waters, C. (2)
Kim, YJ (2)
Carr, J. (2)
Mollenhauer, B. (2)
De Rosa, A. (2)
Groop, Leif (2)
Klein, C. (2)
Vidailhet, M (2)
Dibattista, Michele (2)
Menini, Anna (2)
Franks, Paul W. (2)
Belin, AC (2)
Zieminska, Kasia (2)
Hansen, Torben (2)
Koivula, Robert Wilh ... (2)
Tobias, Deirdre Kay (2)
Ran, C. (2)
Hentati, F (2)
Foroud, T (2)
Clarimón, J. (2)
Hattersley, Andrew T (2)
Suchowersky, O (2)
Gloyn, Anna L (2)
Pereda-Loth, Veronic ... (2)
Pierron, Denis (2)
Padmanabhan, S. (2)
visa färre...
Lärosäte
Lunds universitet (7)
Karolinska Institutet (4)
Stockholms universitet (3)
Uppsala universitet (2)
Göteborgs universitet (1)
Linköpings universitet (1)
visa fler...
Karlstads universitet (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (13)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (8)
Naturvetenskap (3)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy